Synbio International Inc. (SYIN)
Market Closed
12 Aug, 20:00
OTC PINK OTC PINK Primary $
0. 00
-0
-20%
$
239.06K Market Cap
- P/E Ratio
- Div Yield
4.12M Volume
0 Eps
$ 0
Previous Close Want to track SYIN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Synbio International Inc. Expands its Board of Directors and Strengthens its Clinical Leadership with the Appointment of Dr. Nick Vatakis
Dr. Vatakis, appointed as Medical Director, brings decades of clinical trial leadership, advancing Synbio's credibility and the integrity of its upcoming feasibility trial New York City, October 22, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Synbio International Inc.
Prismmediawire | 9 months ago
Synbio International Inc. Strengthens Strategic Alliance with FacialDx Inc. through Share Purchase and Warrant Agreements
New York, NY, October 08, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Synbio International Inc. (OTC: SYIN) (“Synbio” or the “Company”) is pleased to announce the execution of a Share Purchase Agreement and Warrant Agreement (SPA) with FacialDx, Inc.
Prismmediawire | 10 months ago
